A Team Dedicated to Building Collaborations and Partnerships
Strategic collaborations and partnerships have been an important part of our development and growth as a biopharmaceutical company. The following graphic illustrates our development and commercialization strategy:

We are currently looking for partnership opportunities for certain novel small-molecule therapeutics derived from our boron chemistry platform in the following areas:

• Dermatology: We are currently seeking Ex-U.S. partnership opportunities for our dermatology portfolio which includes products in preclinical and clinical for psoriasis, tinea pedis and atopic dermatitis.


• Autoimmune/Inflammation/Respiratory: We are currently seeking partnership and R&D collaboration opportunities for systemic applications of our anti-inflammatory compounds based on our boron chemistry platform.


• Oral care: We are currently looking for partnership opportunities for AN0128 for potential use in oral care. AN0128 demonstrates dual anti-inflammatory and anti-bacterial activity. We believe that this combination of antibiotic and anti-inflammatory properties gives AN0128 the potential to treat a number of indications, including gingivitis.

Strategic Alliances

Partnering Opportunities
For more information about business development opportunities, please contact the Business Development Department.

Email
busdev@anacor.com

Mail
Anacor Pharmaceuticals, Inc.
Attn: Business Development Department
1060 East Meadow Circle
Palo Alto, CA 94303